HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Solution

HYQVIA® is a brand-name medication that contains immune globulin infusion 10% (human) with recombinant human hyaluronidase. It is primarily used to treat individuals with primary immunodeficiency disorders. HYQVIA® is a sterile solution that combines immune globulin and recombinant human hyaluronidase. It is designed to increase antibody levels in individuals with primary immunodeficiency disorders, enhancing their immune response.

Indications and Uses

HYQVIA® is indicated for the following purposes:

• Treatment of primary immunodeficiency disorders in adult and pediatric patients.

• It is used to increase antibody levels in individuals with immune system deficiencies.

• The product has limited data on its use for other medical conditions.

Dosage and Administration

The dosage of HYQVIA® is determined by a healthcare provider based on the patient's specific condition and antibody levels. The medication is administered through subcutaneous (under the skin) infusion. The dose and frequency of administration are individualized to the patient's needs.

Contraindications

HYQVIA® should not be used in individuals with known hypersensitivity to immune globulin or any of its components. It is essential to discuss any allergies or potential reactions with a healthcare provider.

Adverse Effects and Side Effects

Common side effects of HYQVIA® may include:

• Injection site reactions, such as pain, redness, and swelling.

• Headache.

• Fatigue.

• Nausea.

• Fever.

Serious side effects are rare but may include:

• Severe allergic reactions, which can manifest as hives, difficulty breathing, and swelling of the face, lips, or tongue.

• Blood clotting disorders.

• Kidney problems.

It is crucial to report any severe or unusual side effects to your healthcare provider.

Storage and Shelf Life

Store HYQVIA® in the refrigerator at 2-8°C (36-46°F). Protect it from light. Do not use HYQVIA® after the expiration date.

Packaging and Presentation

HYQVIA® is available as a sterile solution for subcutaneous infusion.

Regulatory Information

HYQVIA® is subject to regulation by health authorities to ensure its safety and efficacy. It is essential to use this medication as directed by a healthcare professional and in accordance with local regulations.

References

Always consult with your healthcare provider and refer to the official prescribing information and product labeling for the most up-to-date and comprehensive information on HYQVIA®. Your healthcare provider will guide you in the proper use of this medication, monitor your progress, and tailor the treatment to your specific medical condition.